Movement Alert｜DaVita HealthCare Partners Falls 5.61% in Regular Trading, Strong Q3 Results Overshadowed by Modest Guidance Increase

Market Focus10-30 21:59

On October 30, DaVita HealthCare Partners fell 5.61% in Regular Trading, trading at $178.5 per share, with turnover of $73.5977 million.

The move was driven by the company’s latest quarterly results and updated full-year outlook. DaVita HealthCare Partners reported third-quarter adjusted EPS of $3.82 and revenue of $3.58 billion, both above market expectations. However, it raised full-year adjusted EPS guidance only to $14.30-$15.20 from $14.10-$15.20, leaving the upper end unchanged and keeping the midpoint close to consensus expectations, which limited the positive earnings impact.

Additional pressure came from a target price cut by Barclays to $216 from $224. The company also disclosed that it repurchased 382,563 shares from Berkshire Hathaway, though the trading reaction was primarily centered on the limited guidance uplift after an earnings beat.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment